Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at OPKO Health, BioCorRx, Coeptis Therapeutics, and Collective Audience have recently purchased shares of their respective companies, signaling confidence in their prospects. OPKO Health's Vice Chairman and CTO acquired 150,000 shares, while BioCorRx's Interim President bought 3,126 shares. Coeptis Therapeutics' CFO purchased 5,000 shares, and Collective Audience's CEO acquired 20,000 shares. These transactions come amidst various company developments, including OPKO Health's private offering, BioCorRx's stock decline, Coeptis Therapeutics' shareholder letter, and Collective Audience's new COO appointment.
January 18, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioCorRx's Interim President, Louis C Lucido, acquired 3,126 shares at an average price of $0.70, spending approximately $2,188. The company's stock has fallen about 22% over the past month.
Insider buying following a significant stock price drop could be seen as a positive signal, suggesting the insider believes the stock is undervalued.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Collective Audience's CEO, Peter Bordes, acquired 20,000 shares at $0.94 each, spending $18,800. The company recently appointed a new COO, Christopher Andrews.
The CEO's stock purchase and the appointment of a new COO could be perceived as positive developments, potentially leading to a short-term uptick in stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Coeptis Therapeutics' CFO, Brian Cogley, bought 5,000 shares at $0.67 each, totaling $3,350. The company recently reviewed its 2023 achievements and anticipated milestones for 2024.
The CFO's purchase, combined with the company's positive outlook for the future, could encourage investor optimism in the short term.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
OPKO Health's Vice Chairman and CTO, PH Jane Hsiao, purchased 150,000 shares at $0.95 each, totaling $142,500. The company recently announced a $200 million convertible senior notes offering due 2029.
The insider purchase by a high-ranking executive suggests confidence in the company's future, potentially positively influencing investor sentiment in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80